Advances in ANCA-associated vasculitis and lupus nephritis

Nature Reviews Nephrology, Published online: 11 December 2020; doi:10.1038/s41581-020-00388-xIn 2020 a number of clinical trials have provided insights into therapeutic approaches for the treatment of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and lupus nephritis. Moreover, mechanistic insights have potential to open new therapeutic strategies in the future.

http://feeds.nature.com/~r/nrneph/rss/current/~3/W4IEbAuzavE/s41581-020-00388-x

Source: Nature Reviews Nephrology - December 11, 2020 Category: Urology & Nephrology Authors: Isabelle Ayoub Patrick H. Nachman Source Type: research

More News: Clinical Trials | Lupus | Nephritis | Urology & Nephrology | Vasculitis